138 related articles for article (PubMed ID: 36396713)
1. CA125 as a predictor of endometrial cancer lymphovascular space invasion and lymph node metastasis for risk stratification in the preoperative setting.
Shawn LyBarger K; Miller HA; Frieboes HB
Sci Rep; 2022 Nov; 12(1):19783. PubMed ID: 36396713
[TBL] [Abstract][Full Text] [Related]
2. A clinical marker-based modeling framework to preoperatively predict lymph node and vascular space involvement in endometrial cancer patients.
Miller HA; Tran A; LyBarger KS; Frieboes HB
Eur J Surg Oncol; 2024 Jan; 50(1):107309. PubMed ID: 38056021
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for pelvic lymph node metastasis in endometrial cancer.
Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
[TBL] [Abstract][Full Text] [Related]
4. Preoperative CA125 and fibrinogen in patients with endometrial cancer: a risk model for predicting lymphovascular space invasion.
Zhou X; Wang H; Wang X
J Gynecol Oncol; 2017 Mar; 28(2):e11. PubMed ID: 27894164
[TBL] [Abstract][Full Text] [Related]
5. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer.
Sun Y; Wang Y; Cheng X; Wu W; Liu Q; Chen X; Ren F
Eur J Surg Oncol; 2024 Apr; 50(4):108260. PubMed ID: 38484492
[TBL] [Abstract][Full Text] [Related]
7. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
8. The preoperative serum CA125 can predict the lymph node metastasis in endometrioid-type endometrial cancer.
Ünsal M; Kimyon Comert G; Karalok A; Basaran D; Turkmen O; Boyraz G; Tasci T; Koc S; Boran N; Tulunay G; Turan T
Ginekol Pol; 2018; 89(11):599-606. PubMed ID: 30508211
[TBL] [Abstract][Full Text] [Related]
9. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
[TBL] [Abstract][Full Text] [Related]
10. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
[TBL] [Abstract][Full Text] [Related]
11. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
[TBL] [Abstract][Full Text] [Related]
12. Preoperative CA125 Significantly Improves Risk Stratification in High-Grade Endometrial Cancer.
Lombaers MS; Cornel KMC; Visser NCM; Bulten J; Küsters-Vandevelde HVN; Amant F; Boll D; Bronsert P; Colas E; Geomini PMAJ; Gil-Moreno A; van Hamont D; Huvila J; Krakstad C; Kraayenbrink AA; Koskas M; Mancebo G; Matías-Guiu X; Ngo H; Pijlman BM; Vos MC; Weinberger V; Snijders MPLM; van Koeverden SW; Enitec-Consortium ; Haldorsen IS; Reijnen C; Pijnenborg JMA
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174070
[TBL] [Abstract][Full Text] [Related]
13. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
Vaizoglu F; Yuce K; Salman MC; Basaran D; Calis P; Ozgul N; Usubutun A
Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
[TBL] [Abstract][Full Text] [Related]
14. Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer.
Lei H; Xu S; Mao X; Chen X; Chen Y; Sun X; Sun P
J Inflamm Res; 2021; 14():7131-7142. PubMed ID: 34992410
[TBL] [Abstract][Full Text] [Related]
15. Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.
Gumtorntip P; Poomtavorn Y; Tanprasertkul C
Asian Pac J Cancer Prev; 2022 Feb; 23(2):617-622. PubMed ID: 35225474
[TBL] [Abstract][Full Text] [Related]
16. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
18. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
[TBL] [Abstract][Full Text] [Related]
19. Novel preoperative predictive score to evaluate lymphovascular space involvement in endometrial cancer: an aid to the sentinel lymph node algorithm.
Capozzi VA; Sozzi G; Uccella S; Ceni V; Cianciolo A; Gambino G; Armano G; Pugliese M; Scambia G; Chiantera V; Berretta R
Int J Gynecol Cancer; 2020 Jun; 30(6):806-812. PubMed ID: 32284322
[TBL] [Abstract][Full Text] [Related]
20. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
